Novartis Files Suit To Stop Chinese Entresto Generic
Swiss pharmaceutical giant Novartis AG filed a patent infringement suit Monday claiming China's Nanjing Noratech Pharmaceutical Co. is attempting to manufacture and distribute a generic version of the heart medication Entresto...To view the full article, register now.
Already a subscriber? Click here to view full article